{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:43:28Z","timestamp":1694637808612},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T00:00:00Z","timestamp":1256860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,30]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The posters presented at the 6th International Immunoglobulin Symposium covered a wide range of fields and included both basic science and clinical research. From the abstracts accepted for poster presentation, 12 abstracts were selected for oral presentations in three parallel sessions on immunodeficiencies, autoimmunity and basic research. The immunodeficiency presentations dealt with novel, rare class-switch recombination (CSR) deficiencies, attenuation of adverse events following IVIg treatment, association of immunoglobulin (Ig)G trough levels and protection against acute infection in patients with X-linked agammaglobulinaemia (XLA) and common variable immunodeficiency (CVID), and the reduction of class-switched memory B cells in patients with specific antibody deficiency (SAD). The impact of intravenous immunoglobulin on fetal alloimmune thrombocytopenia, pregnancy and postpartum-related relapses in multiple sclerosis and refractory myositis, as well as experiences with subcutaneous immunoglobulin in patients with multi-focal motor neuropathy, were the topics presented in the autoimmunity session. The interaction of dendritic cell (DC)-SIGN and \u03b12,6-sialylated IgG Fc and its impact on human DCs, the enrichment of sialylated IgG in plasma-derived IgG, as wells as prion surveillance and monitoring of anti-measles titres in immunoglobulin products, were covered in the basic science session. In summary, the presentations illustrated the breadth of immunoglobulin therapy usage and highlighted the progress that is being made in diverse areas of basic and clinical research, extending our understanding of the mechanisms of immunoglobulin action and contributing to improved patient care.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2009.04028.x","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T18:33:24Z","timestamp":1256927604000},"page":"60-67","source":"Crossref","is-referenced-by-count":11,"title":["6th International Immunoglobulin Symposium: Poster presentations"],"prefix":"10.1093","volume":"158","author":[{"given":"E","family":"Fernandez-Cruz","sequence":"first","affiliation":[{"name":"Complutense University and University Hospital, Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S V","family":"Kaveri","sequence":"additional","affiliation":[{"name":"INSERM U872, Centre de Recherche des Cordeliers"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-H","family":"Peter","sequence":"additional","affiliation":[{"name":"Freiburg University Hospital, Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Durandy","sequence":"additional","affiliation":[{"name":"INSERM U768, Universit\u00e9 Paris V-Rene Descartes, Hospital Necker, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Cantoni","sequence":"additional","affiliation":[{"name":"University Hospital Basel, Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Quinti","sequence":"additional","affiliation":[{"name":"Sapienza University of Rome, Rome"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sorensen","sequence":"additional","affiliation":[{"name":"LSU Health Sciences Center and Children's Hospital, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J B","family":"Bussel","sequence":"additional","affiliation":[{"name":"Weill Medical College of Cornell University, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M G","family":"Danieli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Politechnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Winkelmann","sequence":"additional","affiliation":[{"name":"University of Rostock, Rostock"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bayry","sequence":"additional","affiliation":[{"name":"INSERM U872, Centre de Recherche des Cordeliers"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"K\u00e4sermann","sequence":"additional","affiliation":[{"name":"CSL Behring AG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Sp\u00e4th","sequence":"additional","affiliation":[{"name":"University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Helbert","sequence":"additional","affiliation":[{"name":"Manchester Royal Infirmary, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Salama","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Campus Virchow Klinikum, Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I N","family":"Van Schaik","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Yuki","sequence":"additional","affiliation":[{"name":"Niigata National Hospital, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,10,30]]},"reference":[{"key":"2021122708525529200_b1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12026-007-0003-5","article-title":"Safety of IGIV therapy and infusion-related adverse events","volume":"38","author":"Ballow","year":"2007","journal-title":"Immunol Res"},{"key":"2021122708525529200_b2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000083948","article-title":"Immunoglobulin replacement therapy in primary antibody deficiency diseases \u2013 maximizing success","volume":"136","author":"Durandy","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"2021122708525529200_b3","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1084\/jem.20080789","article-title":"Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination","volume":"205","author":"P\u00e9ron","year":"2008","journal-title":"J Exp Med"},{"key":"2021122708525529200_b4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni974","article-title":"Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination","volume":"4","author":"Imai","year":"2003","journal-title":"Nat Immunol"},{"key":"2021122708525529200_b5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cell.2006.05.039","article-title":"Endonucleolytic function of MutLalpha in human mismatch repair","volume":"126","author":"Kadyrov","year":"2006","journal-title":"Cell"},{"key":"2021122708525529200_b6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse effects of intravenous immunoglobulin therapy","volume":"21","author":"Nydegger","year":"1999","journal-title":"Drug Saf"},{"key":"2021122708525529200_b7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1423-0410.1962.tb03240.x","article-title":"Intravenous administration of human g-globulin","volume":"7","author":"Barandun","year":"1962","journal-title":"Vox Sang"},{"key":"2021122708525529200_b8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaci.2008.08.033","article-title":"Intravenous immunoglobulin: adverse reactions and management","volume":"122","author":"Bonilla","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708525529200_b9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.iac.2008.01.008","article-title":"Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency","volume":"28","author":"Berger","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"2021122708525529200_b10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beha.2005.01.032","article-title":"Use of intravenous immunoglobulin G (IVIG)","volume":"19","author":"Looney","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"2021122708525529200_b11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tmrv.2008.05.003","article-title":"Diagnosis and management of neonatal alloimmune thrombocytopenia","volume":"22","author":"Arnold","year":"2008","journal-title":"Transfus Med Rev"},{"key":"2021122708525529200_b12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ajog.2006.05.001","article-title":"Alloimmune thrombocytopenia: state of the art 2006","volume":"195","author":"Berkowitz","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"2021122708525529200_b13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2021122708525529200_b14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122708525529200_b15","first-page":"322","article-title":"Intravenous immunoglobulin treatment in autoimmune diseases","volume":"98","author":"Danieli","year":"2007","journal-title":"Recenti Prog Med"},{"key":"2021122708525529200_b16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1468-1331.2006.01466.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of multifocal motor neuropathy","volume":"13","author":"European Federation of Neurological Societies, Peripheral Nerve Society","year":"2006","journal-title":"Eur J Neurol"},{"key":"2021122708525529200_b17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122708525529200_b18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"Vukusic","year":"2004","journal-title":"Brain"},{"key":"2021122708525529200_b19","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1073\/pnas.0900016106","article-title":"DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells","volume":"106","author":"Bayry","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"2021122708525529200_b20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07376.x","article-title":"An update on the assessment and management of the risk of transmission of variant Creutzfeldt\u2013Jakob disease by blood and plasma products","volume":"144","author":"Turner","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122708525529200_b21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","article-title":"Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin","volume":"101","author":"Bayry","year":"2003","journal-title":"Blood"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2009.04028.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/158\/Supplement_1\/60\/41926177\/j.1365-2249.2009.04028.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/158\/Supplement_1\/60\/41926177\/j.1365-2249.2009.04028.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:22:00Z","timestamp":1641054120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/158\/Supplement_1\/60\/6428880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,30]]},"references-count":21,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2009,10,30]]},"published-print":{"date-parts":[[2009,10,30]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04028.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,12]]},"published":{"date-parts":[[2009,10,30]]}}}